How big is the Global Antiparasitic Drugs Market?

The Global Antiparasitic Drugs Market size is expected to reach USD 24.61 billion in 2024 and grow at a CAGR of 5.53% to reach USD 32.20 billion by 2029. Read More

What is the current Global Antiparasitic Drugs Market size?

In 2024, the Global Antiparasitic Drugs Market size is expected to reach USD 24.61 billion. Read More

Who are the key players in Global Antiparasitic Drugs Market?

Merck KGaA, Novartis AG, F. Hoffmann-La Roche Ltd, Bayer AG and GSK plc are the major companies operating in the Global Antiparasitic Drugs Market. Read More

Which is the fastest growing region in Global Antiparasitic Drugs Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Global Antiparasitic Drugs Market?

In 2024, the North America accounts for the largest market share in Global Antiparasitic Drugs Market. Read More

What years does this Global Antiparasitic Drugs Market cover, and what was the market size in 2023?

In 2023, the Global Antiparasitic Drugs Market size was estimated at USD 23.25 billion. The report covers the Global Antiparasitic Drugs Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Antiparasitic Drugs Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Global Antiparasitic Drugs Market Share

Statistics for the 2023 & 2024 Global Antiparasitic Drugs market share, created by Mordor Intelligence™ Industry Reports. Global Antiparasitic Drugs share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Global Antiparasitic Drugs Industry

The antiparasitic drugs market is fragmented, with several key players. Companies are investing in R&D to develop new drugs, improve existing treatments, and create combination therapies to address drug resistance and enhance efficacy. In addition, collaborations and alliances with research institutions and global health organizations help in drug development and distribution, particularly in underserved regions. Some key players in the market include F. Hoffmann-La Roche, Novartis AG, GSK PLC, Bayer AG, and Merck KGaA.